Study details
Enrolling now
Delivery SSO2 Therapy for 60 Min in Anterior MI Patients With PCI ≤ 6 Hours of Symptoms Onset Compared to Standard
TherOx
NCT IDNCT04743245ClinicalTrials.gov data as of Apr 2026
Target enrollment
434
Study length
about 3.7 years
Ages
18+
Locations
1 site in MA
About this study
This trial is testing a new treatment, Delivery SSO2 therapy, given through a device (TherOx DownStream System) to patients who have had a heart attack (anterior MI). It compares this new treatment to standard care for these patients.
Based on ClinicalTrials.gov records.
What participants do
- 1.Use PCI
- 2.Use TherOx DownStream System
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low13%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Body systems
Cardiology / Heart